大麻使用与精神分裂症作为危险因素或其治疗潜力的关系:对证据的系统审查
Jaisingh Rajput1, Sandhya Narahari2, Taha Arif3
1Family Medicine, Baptist Health, Montgomery, USA.
Cureus
|October 23, 2025
概括
使用高THC大麻会增加精神分裂症的风险,特别是在青少年和弱势群体中. 大麻 (CBD) 显示出治疗精神分裂症的前景,但需要更多的研究.
科学领域:
- 精神病学和神经科学 精神病学和神经科学
- 药理学 药理学是指药理学的学科.
- 大麻研究 大麻研究
背景情况:
- 医用大麻使用量的增加引发了关于心理效应的辩论,特别是在精神分裂症方面.
- 德尔塔-9-四大麻 (THC) 是已知的精神病风险因素,而大麻 (CBD) 正在探索治疗益处.
研究的目的:
- 分析科学文献并澄清争议:大麻是否会使精神分裂症症状恶化?
- 为了区分THC和CBD对精神分裂症的影响.
主要方法:
- 按照PRISMA 2020指南进行系统审查.
- 在PubMed,PubMed Central,Cochrane图书馆和谷歌学者 (2017-2025) 中进行了搜索.
- 包括使用AMSTAR 2,Cochrane偏差风险和SANRA工具进行严格评估后的8项高质量研究.
主要成果:
- 高THC大麻的使用显著增加了精神分裂症的风险,特别是在青少年和家庭脆弱的人群中.
- 在已确定的精神分裂症患者中,THC会加剧积极,消极和认知症状.
- 虽然临床证据有限,但CBD显示出抗精神病和神经保护性质,表明治疗潜力.
结论:
- 在精神病学讨论中,区分大麻成分 (THC与CBD) 是至关重要的.
- THC对精神分裂症具有显著的风险,而CBD是一个有前途的治疗候选者.
- 进一步的大规模临床试验对于确定CBD在精神分裂症治疗中的治疗和机制作用至关重要.
相关概念视频
Psychological and Sociocultural Causes of Schizophrenia
466
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
466
Biological Causes of Schizophrenia
486
Schizophrenia, a severe psychiatric disorder, arises from a complex interplay of biological factors, including genetic predisposition, structural brain abnormalities, neurotransmitter dysregulation, and developmental irregularities. These factors collectively contribute to the onset and progression of the disorder, which typically manifests in late adolescence or early adulthood.
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
Genetic Factors in Schizophrenia
The genetic basis of schizophrenia is strongly supported by family and twin...
486
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
1.8K
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
1.8K
Hallucinogens and Psychedelics
596
Hallucinogens are psychoactive substances that profoundly alter perceptual experiences, generating unreal visual and sensory images. Often referred to as psychedelic drugs — a term derived from the Greek words "psyche" (mind) and "delos" (revealing) — these substances include marijuana and lysergic acid diethylamide (LSD), among others. These drugs vary in intensity and effects.
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
Marijuana, derived from the dried leaves and flowers of the hemp plant, contains...
596
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
666
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
666
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
772
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
772


